Emma Zattarin

8PUBLICATIONS
38CO-AUTHORS
Cancer diagnosisCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 16, 2025
Breast cancer and large-cell neuroendocrine carcinoma harboring the same PIK3CA mutation: A case report.

Emma Zattarin, Teresa Beninato, Giorgia Di Liberti

|Jul 01, 2025
Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last Decade.

Emma Zattarin, Luca Moscetti, Elisa D'Agostino

|Dec 22, 2023
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.

Emma Zattarin, Luigi Mariani, Alice Menichetti

|Oct 31, 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research.

Fabio Conforti, Laura Pala, Tommaso De Pas

|Apr 17, 2023
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.

Leonardo Provenzano, Riccardo Lobefaro, Francesca Ligorio

|Jun 20, 2022
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.

Emma Zattarin, Sara Manglaviti, Giulia Apollonio

Pageof 2

Frequent Collaborators

2 joint publications

Achille Bottiglieri

2 joint publications

Caterina Sposetti

2 joint publications

Rita Leporati

1 joint publications

Federico Nichetti